argenx to acquire Unnatural Products for up to $1.15 billion
ARGX•argenx will acquire Unnatural Products in a deal valued at up to $1.15 billion, including upfront and milestone payments. The boards of both companies approved the transaction, which is expected to close by year-end, subject to customary conditions.
1. Deal details
argenx will acquire Unnatural Products, adding its peptide discovery engine to broaden argenx’s immunology capabilities. The deal is valued at up to $1.15 billion, including upfront and milestone payments. Both companies’ boards approved the transaction, which is expected to close by the end of the year, subject to customary closing conditions.
